Managing and treating renal impairment in multiple myeloma

In this video, Joan Bladé, MD, PhD, University of Barcelona, Barcelona, Spain, discusses the management and treatment of renal impairment in patients with multiple myeloma. Prof. Bladé first highlights the poorer outcomes associated with patients who present with severe renal impairment, and then discusses potential treatment combinations, including bortezomib plus dexamethasone and a third agent. Following this, Prof. Bladé shares some insights into his presentation at COMy 2022, which focused on a long-term follow-up of patients with renal impairment and the improvements that have been made in these patients over the last 50 years. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.